User menu

Dasatinib (Sprycel®) use in daily clinical practice : a Belgian observational retrospective study in patients with chronic myeloid leukaemia and Philadelphia positive acute lymphatic leukaemia who are resistant or intolerant to prior therapies including imatinib

Bibliographic reference Martiat, Ph. ; Bosly, André ; Noens, L. ; Verhoef, G. ; Houssa, B. ; et. al. Dasatinib (Sprycel®) use in daily clinical practice : a Belgian observational retrospective study in patients with chronic myeloid leukaemia and Philadelphia positive acute lymphatic leukaemia who are resistant or intolerant to prior therapies including imatinib. In: Belgian Journal of Hematology, Vol. 3, no.2, p. 51-58 (2012)
Permanent URL http://hdl.handle.net/2078.1/124236